♟️ Wednesday 15 January 2025 Wed, 15 Jan 2025

9 Move Signals

5E Advanced Materials Unveils $30M Funding and Convertible Note Restructuring

5E Advanced Materials has entered a pivotal Restructuring Support Agreement with its primary lenders to equitize $63.5 million in convertible notes and secure up to $30 million in funding. The transaction, subject to shareholder approval, aims to strengthen the balance sheet and advance the company toward its Final Investment Decision.
15 Jan
Maxwell Dee
Maxwell Dee

Greenwing Unveils 1.07Mt LCE Maiden Resource at San Jorge Lithium Project

Greenwing Resources has announced a maiden Mineral Resource Estimate of 1.07 million tonnes Lithium Carbonate Equivalent at its San Jorge Lithium Brine Project in Argentina, with promising geophysical data suggesting significant upside potential.
15 Jan
Maxwell Dee
Maxwell Dee

Orthocell Surges with Record $2.21M Revenue and US FDA Submission

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.
15 Jan
Ada Torres
Ada Torres

Sipa Resources Accelerates Growth with $2.2M Gold Project Acquisition

Sipa Resources has inked agreements to acquire four advanced gold projects in South Australia and Western Australia, positioning itself for a significant exploration boost. The $2.2 million deal, coupled with a $1.75 million capital raise, signals a strategic pivot towards expanding its resource base.
15 Jan
Victor Sage
Victor Sage

Beacon Minerals Surpasses Gold Production Targets with 6,861 Ounces in Q4

Beacon Minerals Limited has reported a strong December quarter at its Jaurdi Gold Project, producing 6,861 ounces of gold-exceeding guidance and setting the stage for further growth in 2025.
15 Jan
Maxwell Dee
Maxwell Dee

5E Advanced Materials Secures $30M Funding Boost and Board Restructure

5E Advanced Materials has announced a $30 million funding package alongside a significant restructuring of its convertible notes, aiming to strengthen its balance sheet and advance toward a Final Investment Decision.
15 Jan
Maxwell Dee
Maxwell Dee

Anatara Lifesciences Pauses IBS Trial Recruitment Ahead of Q1 2025 Results

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.
15 Jan
Ada Torres
Ada Torres

Arafura Secures A$200 Million Boost for Nolans Rare Earths Project

Arafura Rare Earths has locked in a A$200 million convertible note investment from the National Reconstruction Fund Corporation, marking a pivotal step toward developing Australia's first ore-to-oxide rare earths processing operation at Nolans.
15 Jan
Maxwell Dee
Maxwell Dee

AUCyber Battles $1.6M Loss, Rejects 5GN Takeover Bid Amid Integration Woes

AUCyber Limited reveals a challenging half-year with a $1.6 million EBITDA loss on $12.2 million revenue, alongside operational setbacks and a rejected takeover bid from 5GN Networks.
15 Jan
Sophie Babbage
Sophie Babbage